BRF2 and ovarian cancer: BDP1 mRNA expression was significantly decreased in ovarian cancer, p = 0.01 (Figure 2A) but the expression of other TFIIIB subunits, BRF1 (Figure 2B), BRF2 (Figure 2C), and TBP (Figure 2D), was not significantly changed.